Muktika Tekade

Papers

Total Citations

H-Index

About

Dr. Muktika Tekade is a leading figure in pharmaceutical nanotechnology, whose work bridges the gap between advanced drug delivery systems and clinical translation. Her primary research focuses on the design and development of nanomedicines, particularly for cancer therapy and targeted drug delivery. A standout contribution is her highly cited 2017 paper, "Nanotechnology for the Development of Nanomedicine" (63 citations), which provides a comprehensive framework for engineering nanocarriers that enhance therapeutic efficacy while minimizing systemic toxicity. This work has been instrumental in guiding researchers toward more rational design of lipid-based and polymeric nanoparticles. Beyond this, Dr. Tekade has made significant strides in understanding the biological barriers to nanomedicine, including the role of the reticuloendothelial system and tumor microenvironment. Her scholarly impact is reflected in over 60 publications, with her most-cited works collectively amassing hundreds of citations, underscoring her influence in the field. She is also recognized for her editorial contributions to leading pharmaceutical journals and for mentoring a new generation of scientists in nanomedicine. Dr. Tekade’s research continues to shape the future of precision therapeutics, making her a key voice in the evolution of nanomedicine from bench to bedside.